Pulmonary Hypertension in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms; an Observational Prospective Study
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 180
- 试验地点
- 1
- 主要终点
- Prevalence of pulmonary hypertension at initial presentation and first echo
研究概览
简要总结
This is an observational prospective study aiming to clarify the prevalence of pulmonary hypertension in patients with Myeloproliferative Neoplasms and their prognosis.
All patients attending our department with the above mentioned neoplasms will be offered inclusion in this study. All will have an echo performed and patients identified as being at risk of pulmonary hypertension will be offered complete investigation as specified by the European Cardiology Association.
All patients will be followed up for a total of five years to identify prognosis.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Myeloproliferative Neoplasms (PV, ET, PMF according to WHO classification)
排除标准
- •Pregnancy
- •Lack of informed consent
- •Age < 18 years
- •Cognitive dysfunctions
结局指标
主要结局
Prevalence of pulmonary hypertension at initial presentation and first echo
时间窗: Initial recruitment
次要结局
- Mortality(1 and 5 years)
- Incidence of pulmonary hypertension while under follow-up(5 years)
研究者
Mette Brabrand
Staff Specialist
Odense University Hospital
